Pioglitazone Hcl 30 mg Tablets bulk supplier for pharma manufacturers

Pioglitazone Hcl 30 Mg Tablets 15 mg, 30 mg, 45 mg Suppliers & Bulk Manufacturers

Available Forms: Oral Tablets

Available Strengths: 15 mg, 30 mg, 45 mg

Reference Brands: Glustin (EU), Actos (USA, EU)

Category: Diabetes

Pioglitazone enhances insulin sensitivity by activating PPAR-γ receptors in adipose tissue, muscle, and liver, improving glucose uptake and reducing hepatic glucose production. It lowers HbA1c levels effectively and can be used with metformin or insulin. Benefits include better glycemic control and preserved β-cell function in type 2 diabetes management.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Pioglitazone tablets are FDA-approved in the USA and authorized by the EMA in the EU for the treatment of type 2 diabetes mellitus, either as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas. Marketed under brands such as Actos, Glustin, and their generics, pioglitazone is classified as a thiazolidinedione. It improves glycemic control by enhancing insulin sensitivity in muscle and adipose tissues. Regulatory agencies emphasize cardiovascular risk evaluation and monitor for adverse effects like weight gain and edema. Pharmatradz.com offers regulatory-compliant sourcing and B2B access to pioglitazone from audited manufacturers globally.

Pioglitazone Hcl 30 Mg Tablets — third party manufacturing & bulk supply

Pioglitazone Hcl 30 Mg Tablets 15 mg, 30 mg, 45 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Pioglitazone Hcl 30 Mg Tablets is supplied as Oral Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Pioglitazone Hcl 30 Mg Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Pioglitazone Hcl 30 Mg Tablets →

Back to Listing

Frequently Asked Questions

Pioglitazone Hydrochloride is used as an oral antidiabetic medication to improve glycemic control in adults with type 2 diabetes mellitus, either alone or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin. It is taken together with diet and exercise to help lower blood glucose levels.

Pioglitazone Hydrochloride is the hydrochloride salt of pioglitazone, a thiazolidinedione (TZD) class compound that activates peroxisome proliferator‑activated receptor gamma (PPAR‑γ) to enhance insulin sensitivity in peripheral tissues and liver.

Common trade names for Pioglitazone Hydrochloride include Actos®, and in some regions products are marketed as Glustin®, Glizone®, or Pioz® among others.

Pioglitazone Hydrochloride is manufactured by multiple pharmaceutical companies globally, including the originator Takeda Pharmaceuticals for Actos® and various generic manufacturers.

The generic name is Pioglitazone Hydrochloride.

Brand names include Actos®, Glustin®, Glizone®, Pioz®, and other regional brands depending on the manufacturer and market.

Pioglitazone Hydrochloride is manufactured in various countries including the USA, EU, India, and other regions by different pharmaceutical companies that produce both branded and generic versions.